Incentives for orphan drug research and development in the United States

BACKGROUND: The Orphan Drug Act (1983) established several incentives to encourage the development of orphan drugs (ODs) to treat rare diseases and conditions. This study analyzed the characteristics of OD designations, approvals, sponsors, and evaluated the effective patent and market exclusivity l...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Seoane-Vazquez, Enrique, Rodriguez-Monguio, Rosa, Szeinbach, Sheryl L, Visaria, Jay
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2008
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2631478/
https://ncbi.nlm.nih.gov/pubmed/19087348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-3-33
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky